Researchers answer brain tumour 'cell of origin' question

Sonic Healthcare to acquire Swiss laboratory group

Most of Australia's leading healthcare firms are expected to post strong first-half profit growth and provide positive outlook statements as the benefits of takeovers and spin-offs start to filter through, according to analysts.

Regenera (ASX:RGA) has appointed Hon Dr Michael Woodridge as non-executive chairman effective immediately, subject to shareholder approval.

The executive director of the Austin Research Institute, Mark Hogarth, has resigned as a director of Prima Biomed (ASX:PRR). The company cited Hogarth's increased responsibilities at the ARI for his resignation.

Decades ago, ranchers who moved their sheep up to the high-altitude summer pastures of the Californian Sierra found lambs were being stillborn with gross deformities, including a distorted skull with a single eye, a forebrain with the hemispheres are fused into a single mass, and lacking a medulla, a collapsed chest without lungs, and a long proboscis-like nose.